Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verona Pharma plc | Director | Share Options (Right to Buy) | 240K | Apr 29, 2024 | Direct | ||
Bolt Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 12, 2024 | Direct | ||
IMPEL PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 13.2K | Jun 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
VRNA | Verona Pharma plc | Apr 29, 2024 | 1 | $0 | 4 | Apr 30, 2024 | Director |
IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
VRNA | Verona Pharma plc | Apr 28, 2023 | 1 | $0 | 4 | Apr 28, 2023 | Director |
IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
VRNA | Verona Pharma plc | Apr 28, 2022 | 1 | $0 | 4 | Apr 29, 2022 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Mar 24, 2022 | 1 | $0 | 4 | Mar 28, 2022 | Director |
VRNA | Verona Pharma plc | Aug 9, 2021 | 1 | $0 | 4 | Aug 10, 2021 | Director |
IMPL | IMPEL NEUROPHARMA INC | Jul 11, 2021 | 1 | $0 | 4 | Jul 13, 2021 | Director |